A Rare Case of Collecting Duct Carcinoma: A Comprehensive Analysis Using Ultrasound, Computed Tomography, and Histopathological Examination. [PDF]
Collecting duct renal cell carcinoma (cdRCC) is an exceptionally rare and aggressive subtype of renal cell carcinoma, accounting for approximately 1% of all renal tumors.
B S +4 more
europepmc +2 more sources
Metastatic Renal Medullary and Collecting Duct Carcinoma in the Era of Antiangiogenic and Immune Checkpoint Inhibitors: A Multicentric Retrospective Study. [PDF]
Simple Summary Collecting duct carcinoma (CDC) and renal medullary carcinoma (RMC) are two rare cancers with a very poor prognosis. Currently, first-line treatment is a platinum-based doublet, but very few studies have evaluated the effectiveness of ...
Guillaume Z +16 more
europepmc +2 more sources
BONSAI-2 study: Nivolumab as therapeutic option after cabozantinib failure in metastatic collecting duct carcinoma patients. [PDF]
Background: The BONSAI phase II trial recently demonstrated the activity of cabozantinib in metastatic collecting duct patients. The outcomes of patients in this setting treated with immunotherapy as second-line is unknown.
Buti S +6 more
europepmc +2 more sources
A Novel Machine Learning Algorithm Combined With Multivariate Analysis for the Prognosis of Renal Collecting Duct Carcinoma. [PDF]
Objectives To investigate the clinical and non-clinical characteristics that may affect the prognosis of patients with renal collecting duct carcinoma (CDC) and to develop an accurate prognostic model for this disease.
Wei L +7 more
europepmc +2 more sources
Bellini Duct Carcinoma: A Rare Entity [PDF]
Bellini duct carcinoma of kidney derives from collecting duct and is associated with an aggressive course and extremely poor prognosis. Here, we report an interesting case of Collecting Duct Carcinoma (CDC) with Inferior Vena Cava (IVC) thrombus and ...
Amit Kumar Mishra +4 more
doaj +1 more source
A durable complete response resulting from treatment with nivolumab plus ipilimumab for metastatic collecting duct carcinoma of the kidney. [PDF]
Funajima K +6 more
europepmc +2 more sources
Introduction Immunotherapy‐based combinations have become the standard first‐line therapy for metastatic renal cell carcinoma. However, combined immunotherapy for renal collecting duct carcinoma had been reported, but its therapeutic efficacy had been ...
Shinji Tamada +8 more
doaj +1 more source
Integrative Transcriptomic Analysis Reveals Distinctive Molecular Traits and Novel Subtypes of Collecting Duct Carcinoma. [PDF]
Simple Summary The treatment of collecting duct carcinoma (CDC) remains unsatisfactory since this highly aggressive kidney cancer has an unfavorable clinical behavior.
Gargiuli C +9 more
europepmc +2 more sources
CT and MRI findings of cystic renal cell carcinoma: comparison with cystic collecting duct carcinoma. [PDF]
Background Cystic renal cell carcinoma (CRCC) and cystic collecting duct carcinoma (CCDC) share similar oncogeni and some imaging findings. The aim of this study was to characterize the clinical and CT imagings features of CRCC and CCDC.
Zhu Q +5 more
europepmc +2 more sources
Renal Collecting Duct Carcinoma and Concomitant Bladder Urothelial Carcinoma: A Case Report
The simultaneous occurrence of renal collecting duct (Bellini duct) carcinoma and bladder urothelial carcinoma is very rare. A 68-year-old female patient with bladder urothelial carcinoma first received transurethral resection of the tumor.
Hsi-Lin Hsiao +7 more
doaj +1 more source

